Position in SLDB
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,650,236
+$5,766,066 QoQ
Shares Held
1,266,290
+32.4% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 155 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 87%
Shared 9%
None 4%
Common Shares in SLDB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. SLDB ranks #71 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in SLDB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,650,236 | 1,266,290 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,884,170 | 956,135 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,830,033 | 679,084 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,736,645 | 443,541 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,082,785 | 222,338 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $997,078 | 269,481 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,056,276 | 264,069 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $497,343 | 71,355 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $401,588 | 70,827 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $872,991 | 65,540 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $306,692 | 49,950 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $138,826 | 55,090 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $325,738 | 62,164 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $267,027 | 56,335 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $299,870 | 55,738 | Shares | Sole | 2023-02-09 | |
| 2022-03-31 | $18,411 | 15,343 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $111,051 | 63,458 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $151,664 | 63,458 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $232,256 | 63,458 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $414,368 | 74,931 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $567,976 | 74,931 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $152,109 | 74,931 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $204,018 | 69,631 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $46,836 | 19,597 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||